Newsroom

LONDON--(BUSINESS WIRE)--  Re: Banque Saudi Fransi USD 20,000,000.00 MATURING: 10-Mar-2032 ISIN: XS3019878035 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 10-Dec-2025 TO 10-Mar-2026 HAS BEEN FIXED AT 5.22 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 10-Mar-2026 WILL AMOUNT TO: USD 13.04 PER USD 1,000.00 DENOMINATION  ...

PEMBROKE, Bermudas--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” o la “Empresa”) anuncia que la Empresa ha presentado su escrito de contestación ante la Corte de Apelaciones de los Estados Unidos para el Tercer Circuito (el “Tercer Circuito”) en relación con la venta judicial propuesta de acciones de PDVH a Elliott/Amber Energy. El escrito de contestación de Gold Reserve afirma que al tribunal de Delaware no se le permitió aprobar la oferta de 590...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Florida Nonprofit Alliance 2025 Survey Reveals financial strain, fundraising challenges and workforce burnout across Florida nonprofits....

NEW YORK--(BUSINESS WIRE)--Money20/20, the world’s leading fintech show and the place where money does business, today announces the return of The Money Awards for its second year, following strong industry engagement and the momentum of its inaugural program. The Money Awards honor and celebrate the companies, innovations, and partnerships shaping the future of finance, recognizing outstanding achievements across the global financial technology sector. The awards, which debuted in 2025, have q...

AIX-EN-PROVENCE, Francia y SAN DIEGO--(BUSINESS WIRE)--Verimatrix (Euronext Paris: VMX), proveedor líder de soluciones de seguridad para mejorar la seguridad del mundo conectado, ha anunciado hoy que su solución Verimatrix ReAccess ha sido galardonada con el premio Gold 2026 Merit Award, dentro de la categoría de telecomunicaciones y soluciones inalámbricas. Este reconocimiento destaca el valor de la solución de seguridad de contenidos de última generación de la empresa, que moderniza los siste...

TORONTO--(BUSINESS WIRE)--Greenland Resources Inc. (TSX:MOLY | FSE: M0LY) („Greenland Resources“ oder das „Unternehmen“) freut sich bekannt zu geben, dass die kanadische Regierung dem Unternehmen eine bedingte Zusage für einen nicht rückzahlbaren Zuschuss von bis zu 7.000.000 Dollar erteilt hat. Diese Mittel dienen der Förderung des Projekts „Malmbjerg Molybdenum Optimization & Magnesium and Rare Earth By-product Feasibility Study“. Vorbehaltlich der abschließenden Due-Diligence-Prüfung und...

AMSTERDAM--(BUSINESS WIRE)--On 18 February the Amsterdam District Court rendered an interim judgment on damages quantification in the proceedings of Macedonian Thrace Brewery ("MTB"), maker of the popular Greek beer Vergina, against Heineken and its subsidiary Athenian Brewery ("AB"). The case stems from the decision of the Greek competition authority, the Hellenic Competition Commission (“HCC”), published in December 2015, that AB abused its dominant position in the Greek beer market for at le...

BRUSSELS--(BUSINESS WIRE)--Regulatory News: Bridger, the copyright management company and part of Winamp Group (Paris: ALWIN) (Brussels: ALWIN), officially confirmed as a Client Rights Management Entity (RME) within the CISAC (International Confederation of Societies of Authors and Composers) ecosystem, further strengthening its global copyright infrastructure. Following the signature of the CISAC Client RME agreement in June 2025, Bridger implemented the required business and technical framewo...

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en médecine de précision pour le traitement des cancers résistants et métastatiques, annonce aujourd'hui avoir obtenu une subvention de 6,92 millions de dollars américains (environ 5,84 millions d'euros) du programme Therapeutic Pipeline Program (TPP) de la Fondation Michael J. Fox pour la recherche sur la maladie de Parkinson...

DIJON, France--(BUSINESS WIRE)--Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of advanced cancers, today announces it has been awarded US $6.92 M (about €5.84 M) grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) Therapeutic Pipeline Program (TPP). The grant aims to prepare OPM’s OPM-201 LRRK2 inhibitor to start its Phase 1b clinical study in 2027...